Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer (TOPO-LAPA)

This study has been terminated.
(lack of efficacy (intermediate analysis))
Sponsor:
Collaborators:
GlaxoSmithKline
Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète
Information provided by:
Centre Francois Baclesse
ClinicalTrials.gov Identifier:
NCT00888810
First received: April 27, 2009
Last updated: NA
Last verified: April 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given